mdj9dup5 | Knowledge4COVID-19

Property	Value
?:abstract	An amendment to this paper has been published and can be accessed via the original article.
?:creator	<https://research.tib.eu/covid-19/entity/Gharebaghi%2C_Naser%3B_Nejadrahim%2C_Rahim%3B_Mousavi%2C_Seyed_Jalil%3B_Sadat-Ebrahimi%2C_Seyyed-Reza%3B_Hajizadeh%2C_Reza>
?:doi	10.1186/s12879-020-05628-w
?:doi	<https://research.tib.eu/covid-19/entity/10.1186/s12879-020-05628-w>
?:journal	BMC_Infect_Dis
?:license	cc-by
?:pmc_json_files	document_parses/pmc_json/PMC7689645.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7689645>
?:pmid	<https://research.tib.eu/covid-19/entity/33243191.0>
?:pmid	33243191.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline; PMC
?:title	Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-26

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/mdj9dup5>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/mdj9dup5>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all